Aethlon Medical (AEMD) Return on Equity (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Return on Equity for 13 consecutive years, with 1.84% as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Return on Equity fell 48.0% year-over-year to 1.84%, compared with a TTM value of 1.84% through Dec 2024, down 48.0%, and an annual FY2024 reading of 1.17%, down 43.0% over the prior year.
- Return on Equity was 1.84% for Q4 2024 at Aethlon Medical, down from 1.53% in the prior quarter.
- Across five years, Return on Equity topped out at 0.37% in Q3 2021 and bottomed at 1.84% in Q4 2024.
- Average Return on Equity over 5 years is 0.89%, with a median of 0.74% recorded in 2022.
- The sharpest move saw Return on Equity soared 1305bps in 2020, then crashed -109bps in 2024.
- Year by year, Return on Equity stood at 0.59% in 2020, then surged by 31bps to 0.41% in 2021, then tumbled by -74bps to 0.71% in 2022, then tumbled by -92bps to 1.37% in 2023, then tumbled by -35bps to 1.84% in 2024.
- Business Quant data shows Return on Equity for AEMD at 1.84% in Q4 2024, 1.53% in Q3 2024, and 1.59% in Q2 2024.